Defeat Duchenne Canada, the country’s leader in Duchenne muscular dystrophy-funded research, is proud to announce that it will grant $880,320 toward five promising research projects this year – making the total awarded over its 29-year history $17.73M.
One in every 5,000 boys is born with Duchenne muscular dystrophy, the most common fatal form of muscular dystrophy. This condition is relentless. It slowly weakens the body’s muscles, deteriorating the function of vital organs and ultimately – shortening their life. Although there are medical treatments in current clinical trials to slow disease progression, there is no cure.
“Research is the only way to find a cure and improve care. But we cannot do this alone – it is a partnership with scientists, clinicians, and families working closely together to serve one common purpose: improving the health and quality of life for children and young adults living with Duchenne muscular dystrophy.”Lisa McCoy, Chief Executive Officer of Defeat Duchenne Canada
The five new projects will enter a three-year agreement with Defeat Duchenne Canada, joining six other research projects in years two and three of their funding.
“As a non-profit organization, Defeat Duchenne Canada relies entirely on donations from our community to invest in the most promising research opportunities. Thanks to our donors’ exceptional vision and generosity, we have funded 61 projects by eminent researchers worldwide. Yet, our journey is far from over, and we remain committed to our mission until all children can live a long and active life.”Lisa McCoy, Chief Executive Officer of Defeat Duchenne Canada
Did you miss the 2023/24 Research Grant Announcement event on January 25, 2024? Watch the recording and hear about the latest progress in Duchenne muscular dystrophy science from our new and currently funded research grant recipients.